Document:

EX-10.13

 Exhibit 10.13 

Employment Term Sheet 
 Set
forth below is an outline of the management compensation terms by which the undersigned parties agree to abide. 
  

			
	Name:	  	Jay Moyes (the “Executive”).
		
	Position:	  	Chief Financial Officer and Executive Member of the Board of Directors for Amedica Corporation (the “Company”).
		
	Start Date:	  	October 30, 2013.
		
	Base Salary:	  	$325,000. The base salary shall be reviewed no less frequently than annually.
		
	Sign on Bonus:	  	$100,000 payable on the first day of employment.
		
	Performance Bonus:	  	The Executive shall participate in the Company’s “Executive Bonus Plan” (or any successor plan), as such plan is implemented on an annual basis as approved by the Board of Directors, it being understood that the
Executive’s actual annual bonus, if any, shall be determined at the discretion of the Company and that if the Executive leaves the Company for any reason other than termination by the Company for Cause, Executive shall be entitled to receive
his annual bonus for that year paid on the earlier of (i) the date that the other participants in the Executive Bonus Plan are paid, or (ii) March 15 of the year following the year to which the bonus relates; provided that Executive shall only be
entitled to receive a pro rated amount based on the number of days the Executive was employed during that calendar year.
		
	Equity Award and Vesting:	  	 Executive shall be awarded a restricted stock unit (RSU) grant in the amount of 1,500,000 units which shall vest upon the occurrence of
the events set forth below:
  

•     500,000 on first day of employment.

 
 •     500,000 upon
successful restructuring of GE Capital debt if prior to January 31, 2014.
  

•     500,000 upon pricing of an IPO if prior to June 30, 2014.

 
 Notwithstanding the foregoing, the issuance of shares of common stock upon the vesting of
the above-referenced RSUs shall be deferred until the earlier of a Change in Control of the Company (as defined below) or Executive’s “separation from service” (as defined below) for any reason, in compliance with Section 409A of the
Internal Revenue Code and the rules and regulations thereunder (“Section 409A”).

		
	Employee Benefits:	  	Participation in the employee benefit plans made available to senior executives of the Company generally.

  
 1 

			
		
	Employment Term:	  	The period beginning from the day on which the Executive begins employment with the Company (the “Start Date”) and shall continue through the date on which it is terminated by the Executive or the Company as provided
for in this Employment Term Sheet or any subsequent employment agreement. The Executive’s obligations hereunder shall survive expiration of the employment term.
		
	Board Membership and Outside Activities:	  	 Executive shall be an Executive Member of the Board of Directors. As an Executive Member, Executive shall not be considered an independent
director nor shall Executive be entitled to any Board fees or other payments for attending Board meetings other than reimbursement of expenses.
  

Executive may continue to serve on those outside company Boards of Directors as Executive currently serves.

		
	Severance/Change in Control Benefits:	  	 (a) In the event of a termination of Executive’s employment by the Company without Cause or by Executive for Good Reason (each as
defined below), then, in addition to any other accrued amounts payable to Executive through the date of termination of Executive’s employment: (1) the Company shall pay Executive a lump-sum severance payment on the date set forth in (c)
below (the “Severance Payment”) in an amount equal to the sum of (x) Executive’s annual base salary as in effect on the date of termination for the Severance Term, as defined below, (y) any unpaid bonus through the
date of Executive’s termination that had been earned but not yet paid for the prior year plus a prorata portion of the Performance Bonus as set forth above, and (z) two times the Executive’s sign on bonus; and (2) provided that
Executive properly elects COBRA continuation coverage, the Company shall pay the COBRA premium for health care coverage for Executive and his spouse and covered dependents, as applicable and to the extent eligible (the “COBRA
Benefits”), for the Severance Term immediately following the date of termination of employment.
  

(b) In the event a Change in Control occurs during the Term and (a) Executive is not offered continued employment by the acquiring company and in
connection therewith Executive’s employment with the Company is terminated by the Company without Cause or by Executive for Good Reason, or (b) Executive is offered continuing employment, but Executive’s employment with the acquiring
company is terminated by the acquiring company without Cause or by Executive for Good Reason, in either event, within twelve (12) months following such Change in Control event, then, in addition to any other accrued amounts payable to Executive
through the date of termination of Executive’s employment, (1) the Executive shall receive a lump-sum severance payment (the “CIC Severance Payment”) in an amount equal to the sum of (x) Executive’s annual base
salary as in effect on the date of termination for the Severance Term, as defined below, (y) any unpaid bonus through the date of Executive’s termination for the prior year that had been earned but not yet paid plus a prorata portion of
the Performance Bonus as set forth above, and (z) two times the Executive’s sign on bonus; and (2) provided that Executive properly elects COBRA continuation coverage, the

  
 2 

			
		  	 COBRA premium for health care coverage for Executive and his spouse and covered dependents, as applicable and to the extent eligible (the
“CIC COBRA Benefits”), for the Severance Term immediately following the date of termination of Executive’s employment. Except as set forth above, Executive shall not be entitled to any CIC Severance Payment or CIC COBRA
Benefits in the event Executive is offered continued employment by the acquiring company following such Change in Control event with the acquiring company assuming this Agreement, or entering into an agreement substantially similar to this
Agreement. In the event of a Change in Control, whether Executive is offered continued employment or not, the above-described RSUs shall fully vest immediately prior to the Change in Control. If Executive is eligible for and entitled to the CIC
Severance Payment or CIC COBRA Benefits, then Executive shall not be eligible for or entitled to the Severance Payment and COBRA Benefits.
  

(c) Any Severance Payment, CIC Severance Payment, COBRA Benefits, or CIC COBRA Benefits vesting and/or any other benefits contemplated by this Section are
conditional on Executive signing and returning to the Company a non-revocable general release of claims providing for a release of all claims relating to Executive’s employment and/or this letter against the Company or its successors,
its subsidiaries and parent company and its and their respective directors, officers and stockholders, in a form satisfactory to the Company (the “Release”); provided that such Release becomes effective and
irrevocable no later than sixty (60) days following Executive’s termination of employment date or such earlier date required by the Release (such deadline, the “Release Deadline”) and such payments to be paid
in a lump sum shall be paid on the date of the Release Deadline. If the Release does not become effective by the Release Deadline, Executive shall forfeit any rights to any Severance Payment, CIC Severance Payment, COBRA Benefits, CIC COBRA
Benefits, vesting and/or any other benefits.
  
 (d) In the event of a termination of
Executive’s employment due to Executive’s Disability (as defined below) or death, the above-described RSUs shall fully vest immediately prior to the date of Executive’s Disability or death. In addition, the Company shall pay the COBRA
premium for health care coverage for Executive (in the event of Disability), Executive’s spouse and covered dependents, as applicable and to the extent eligible (the “COBRA Benefits”), for 18 months immediately
following the date of Executive’s termination. In no event shall Executive or Executive’s estate or beneficiaries be entitled to any of the Severance Payments other than as set forth herein.

 
 (e) In no event shall Executive be entitled to any benefits in the event of a termination
of Executive’s employment by the Company with Cause or by Executive without Good Reason, and Executive shall be entitled solely to Executive’s compensation and other benefits accrued as of the date of Executive’s termination other
than payment of the Performance Bonus as set forth above.

  
 3 

			
		
	Severance Term:	  	24 months.
		
	Cause:	  	“Cause” shall mean (i) Executive’s willful, knowing or grossly negligent failure or refusal to perform Executive’s duties under this Employment Term Sheet or any subsequent employment agreement; (ii)
Executive’s breach of any fiduciary duty to the Company; (iii) material and willful misfeasance or malfeasance by Executive in connection with the performance of Executive’s duties under this Employment Term Sheet or any subsequent
employment agreement; (iv) Executive’s commission of an act which is a fraud or embezzlement; (v) the conviction of Executive for, or a plea of guilty or nolo contendere by Executive to a criminal act which is a felony; (vi) a material breach
or default by Executive of any provision of this Employment Term Sheet or any subsequent employment agreement which has continued for thirty (30) days following notice of such breach or default from the CEO; (vii) Executive’s abuse of drugs or
alcohol to the detriment of the Company;
		
	Disability:	  	“Disability” shall mean the inability of the Executive to perform the principal functions of his duties due to a physical or mental impairment, but only if such inability has lasted or is reasonably expected to last for
at least sixty (60) consecutive days or an aggregate of one hundred twenty (120) days during any twelve-month period. Whether the Executive has a Disability will be determined by a majority of the Board based on evidence provided by one or more
physicians selected by the Board and approved by Executive, which approval shall not be unreasonably withheld.
		
	Good Reason:	  	“Good Reason” shall mean the occurrence of any one or more of the following events without Executive’s prior written consent, subject to the notification and cure provisions below: (i) a material diminution of
Executive’s authority, functions, duties or responsibilities; (ii) a relocation of Executive’s principal workplace more than 50 miles outside the workplace Executive had been assigned to work over the prior six (6) month period; (iii) the
Company’s material diminution of Executive’s annual base salary in effect on the date hereof or as the same may be increased from time to time, other than in the event of a reduction in compensation of all executive officers of the
Company, generally, so long as Executive’s reduction is no more than the average reduction; or (iv) a material breach by the Company of this Agreement; provided that “Good Reason” shall not be deemed to have occurred unless: (1)
Executive provides the Company with written notice that he intends to terminate his employment for one of the grounds set forth in (i)-(iv) within thirty (30) days of such ground occurring, (2) if such ground is capable of being cured, the Company
has failed to cure such ground within a period of thirty (30) days from the date of such written notice, and (3) Executive terminates his employment within sixty one (61) days from the date that Good Reason first occurs.
		
	Change in Control:	  	For purposes hereof, Change in Control shall mean (i) any person (as such term is used in Section 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) becomes the “beneficial
owner” (as defined in

  
 4 

					
		  	Rule 13d-3 under the Act), directly or indirectly, of securities of the Company representing 50% or more of the total voting power represented by the Company’s then outstanding voting securities (excluding for this
purpose the Company or its Affiliates or any employee benefit plan of the Company) pursuant to a transaction or a series of related transactions of which the Board does not approve; (ii) a merger or consolidation of the Company, whether or not
approved by the Board, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting
securities of the surviving entity or the parent of such corporation) at least 50% of the total voting power represented by the voting securities of the Company or such surviving entity or parent of such corporation outstanding immediately
after such merger or consolidation; or (iii) the stockholders of the Company approve an agreement for the sale or disposition by the Company of all or substantially all of the Company’s assets. For purposes of this Employment Term Sheet,
“Change in Control” shall be interpreted in a manner, and limited to the extent necessary, so that it will not cause adverse tax consequences for either party with respect to Section 409A.
		
	Code Section 280G:	  	In the event that Executive becomes entitled to receive or receives any payment or benefit under this Employment Term Sheet or under any other plan, agreement or arrangement with the Company, or any person whose actions
result in a Change in Control or any other person affiliated with the Company or such person (all such payments and benefits being referred to herein as the “Total Payments”) and it is determined that any of the Total Payments shall be
subject to any excise tax pursuant to Section 4999 of the Internal Revenue Code of 1986, as amended, or any similar or successor provision (the “Excise Tax”) then the Company shall make an additional “gross up” payment to
Executive in order to pay the Excise Tax.
		
	Section 409A:	  	If any payments or benefits under this Employment Term Sheet or any subsequent employment agreement that would be considered deferred compensation under Section 409A , then the following rules shall apply:
			
		  	(i)	  	Any termination of Executive’s employment triggering payments or benefits must constitute a “separation from service” under Section 409A(a)(2)(A)(i) of the Code and Treas. Reg. §1.409A-1(h) before distribution
of such benefits can commence. To the extent that the termination of Executive’s employment does not constitute a separation of service under Section 409A(a)(2)(A)(i) of the Code and Treas. Reg. §1.409A-1(h) (as the result of further
services that are reasonably anticipated to be provided by Executive to the Company at the time Executive’s employment terminates), any payments or benefits that constitute non-qualified deferred compensation under Section 409A shall be delayed
until after the date of a subsequent event constituting a separation of service under Section 409A(a)(2)(A)(i) of the Code and Treas. Reg. §1.409A-1(h).

  
 5 

					
		  	(ii)	  	The above-described payments and benefits shall be paid on, or, in the case of installments, shall not commence until, the sixtieth (60th) day following Executive’s termination of employment; provided that if Executive
is deemed at the time of Executive’s separation from service to be a “specified employee” for purposes of Section 409A(a)(2)(B)(i) of the Code, to the extent delayed commencement of any portion of the benefits to which Executive
is entitled under this Employment Term Sheet or any subsequent employment agreement is required in order to avoid an additional tax under Section 409A(a)(1)(B) of the Code, such portion of Executive’s benefits shall not be provided to
Executive prior to the earlier of (a) the first business day following the expiration of the six-month period measured from the date of Executive’s separation from service, (b) the date of Executive’s death, or (c) such
earlier date that shall avoid the imposition of the additional tax under Section 409A(a)(1)(B). Upon the expiration of the applicable six-month period pursuant to Code Section 409A(a)(2)(B)(i), all payments deferred shall be paid in a
lump sum to Executive. It is intended that each installment of the above-described payments and benefits shall be treated as a separate “payment” for purposes of Section 409A.
			
		  	(iii)	  	To the extent that any of the above-described payments or benefits are deemed to be subject to Section 409A, this Employment Term Sheet or any subsequent employment agreement shall be interpreted in accordance with Section 409A
and Department of Treasury regulations and other interpretive guidance issued thereunder in order to (a) preserve the intended tax treatment of the benefits provided with respect to such payments and benefits, and (b) comply with the requirements of
Section 409A. Nothing in this Employment Term Sheet or any subsequent employment agreement shall be construed as a guarantee by the Company of any particular tax effect. The Company shall not be liable to Executive for any tax, penalty, or interest
imposed on any amount paid or payable hereunder by reason of Section 409A, or for reporting in good faith any payment made under this Employment Term Sheet or any subsequent employment agreement as an amount includible in gross income under Section
409A. Neither the Company nor Executive shall have the right to accelerate or defer the delivery of any such payments or benefits except to the extent specifically permitted or required by Section 409A.
		
	Confidentiality; Work Product:	  	Executive shall enter into the Company’s standard Employee Invention Assignment and Confidentiality Agreement.
		
	Governing Law/Forum of Dispute Resolution:	  	This term sheet shall be governed by the laws of Utah, without regard to principles of conflict of laws.

  

					
	Amedica Corporation	  		 	Executive
			
	 /s/ Eric Olson
	  		 	 /s/ Jay M. Moyes

	By: Eric Olson	  		 	

 Its: President and CEO 

  
 6EX-10.14

 Exhibit 10.14 
 INDEMNIFICATION AGREEMENT 
 THIS INDEMNIFICATION AGREEMENT (this
“Agreement”) is made and entered into this              day of
                    , 20    , by and between Amedica Corporation, a Delaware corporation (the “Company”),
and                      (“Indemnitee”). 
 WHEREAS, qualified persons are reluctant to serve corporations as directors, officers or otherwise unless they are provided with broad indemnification and insurance against claims arising out of their
service to and activities on behalf of such corporations; and 
 WHEREAS, the Company has determined that attracting and
retaining such persons is in the best interests of the Company’s stockholders and that it is reasonable, prudent and necessary for the Company to indemnify such persons to the fullest extent permitted by applicable law and to provide reasonable
assurance regarding insurance; 
 NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is
hereby acknowledged, the Company and Indemnitee, each intending to be legally bound, hereby agree as follows: 
 1. Defined
Terms; Construction. 
 (a) Defined Terms. As used in this Agreement, the following terms shall have the following
meanings: 
 “Board of Directors” means the Board of Directors of the Company. 

“Change in Control” means, and shall be deemed to have occurred if, on or after the date of this Agreement, (i) any
“person” (as such term is used in Sections 13(d) and 14(d) of the Exchange Act, as amended), other than (A) a trustee or other fiduciary holding securities under an employee benefit plan of the Company or any of its
subsidiaries acting in such capacity, or (B) a corporation owned directly or indirectly by the stockholders of the Company in substantially the same proportions as their ownership of stock of the Company, is or becomes the
“beneficial owner” (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company representing more than 20% of the total voting power represented by the Company’s then outstanding Voting
Securities, (ii) during any period of two consecutive years, individuals who at the beginning of any such period constitute the Board of Directors and any new director whose election by the Board of Directors or nomination for election
by the Company’s stockholders was approved by a resolution of at least two-thirds (2/3) of the directors then still in office who either were directors at the beginning of the period or whose election or nomination for election was
previously so approved, cease for any reason to constitute a majority thereof, (iii) the stockholders of the Company approve a merger or consolidation of the Company with any other entity other than a merger or consolidation that would
result in the Voting Securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into Voting Securities of the surviving entity) at least eighty percent (80%) of
the total voting power represented by the Voting Securities of the Company or such surviving entity outstanding immediately after such merger or consolidation, (iv) the stockholders of the Company approve a plan of complete liquidation
of the Company or an agreement for the sale or disposition by the Company (in one transaction or a series of related 

  
 1 

 
transactions) of all or substantially all of its assets, or (v) the Company shall file or have filed against it, and such filing shall not be dismissed, any bankruptcy, insolvency or
dissolution proceedings, or a trustee, administrator or creditors committee shall be appointed to manage or supervise the affairs of the Company. 
 “Corporate Status” means the status of a person who is or was a director (or a member of any committee of the Board of Directors), officer, employee or agent (including without limitation a
manager of a limited liability company or general partner of a limited partnership) of the Company or any of its subsidiaries, or of any predecessor thereof, or is or was serving at the request of the Company as a director (or a member of any
committee of the Board of Directors), officer, employee or agent (including without limitation a manager of a limited liability company) of another entity, or of any predecessor thereof, including service with respect to an employee benefit plan.

 “Determination” means a determination that either (x) there is a reasonable basis for the conclusion
that indemnification of Indemnitee is proper in the circumstances because Indemnitee met a particular standard of conduct (a “Favorable Determination”) or (y) there is no reasonable basis for the conclusion that indemnification
of Indemnitee is proper in the circumstances because Indemnitee met a particular standard of conduct (an “Adverse Determination”). An Adverse Determination shall include the decision that a Determination was required in connection with
indemnification and the decision as to the applicable standard of conduct. 
 “DGCL” means the General Corporation Law
of the State of Delaware, as amended from time to time. 
 “Exchange Act” means the Securities Exchange Act of 1934,
as amended. 
 “Expenses” means all (i) attorneys’ fees and expenses, retainers, court, arbitration and
mediation costs, transcription costs, fees and expenses of experts, witness and public relations consultants bonds and fees, traveling expenses, costs of collecting and producing documents, duplication costs, printing and binding costs, telephone
charges, postage, delivery service fees and all other disbursements or expenses of the types customarily incurred in connection with prosecuting, defending, preparing to prosecute or defend, investigating, being or preparing to be a witness in,
appealing or otherwise participating in a Proceeding or responding to, or objecting to, a request to provide discovery in any Proceeding, (ii) damages, judgments, fines and amounts paid in settlement and any other amounts that Indemnitee
becomes legally obligated to pay (including any federal, state or local taxes and ERISA excise taxes imposed on Indemnitee as a result of receipt of reimbursements or advances of expenses under this Agreement) and (iii) the premium, security
for, and other costs relating to any costs bond, supersedes bond or other appeal bond or its equivalent, whether civil, criminal, arbitrational, administrative or investigative with respect to any Proceeding actually and reasonably incurred by
Indemnitee, or on Indemnitee’s behalf, because of any claim or claims made against or by him in connection with any Proceeding, whether formal or informal (including an action by or in the right of the Company), to which Indemnitee is, was or
at any time becomes a party or a witness, or is threatened to be made a party to, participant in or a witness with respect to, by reason of Indemnitee’s Corporate Status. 

  
 2 

 “Independent Legal Counsel” means an attorney or firm of attorneys competent to
render an opinion under the applicable law, selected in accordance with the provisions of Section 5(e), who has not performed any services (other than services similar to those contemplated to be performed by Independent Legal Counsel under
this Agreement) for the Company or any of its subsidiaries or for Indemnitee within the last three years. 

“Proceeding” means a threatened, pending or completed action, suit or proceeding, whether civil, criminal,
administrative or investigative, including without limitation a claim, demand, discovery request, formal or informal investigation, inquiry, administrative hearing, arbitration or other form of alternative dispute resolution, including an appeal
from any of the foregoing. 
 “Voting Securities” means any securities of the Company that vote generally in the
election of directors. 
 (b) Construction. For purposes of this Agreement, 

(i) References to the Company and any of its “subsidiaries” shall include any corporation, limited liability
company, partnership, joint venture, trust or other entity or enterprise that before or after the date of this Agreement is party to a merger or consolidation with the Company or any such subsidiary or that is a successor to the Company as
contemplated by Section 8(e) (whether or not such successor has executed and delivered the written agreement contemplated by Section 8(e)). 

(ii) References to “fines” shall include any excise taxes assessed on Indemnitee with respect to an employee
benefit plan. 
 (iii) References to a “witness” in connection with a Proceeding shall include any
interviewee or person called upon to produce documents in connection with such Proceeding. 
 2. Agreement to Serve.

 Indemnitee agrees to serve as a director of the Company, an officer of the Company, or both, and/or to serve as a director,
officer or both of one or more of the Company’s subsidiaries and in such other capacities as Indemnitee may serve at the request of the Company from time to time, and by its execution of this Agreement the Company confirms its request that
Indemnitee serve as a director, officer and in such other capacities. Indemnitee shall be entitled to resign or otherwise terminate such service with immediate effect at any time, and neither such resignation, termination nor the length of such
service shall affect Indemnitee’s rights under this Agreement. This Agreement shall not constitute an employment agreement, supersede any employment agreement to which Indemnitee is a party or create any right of Indemnitee to continued
employment or appointment. 

  
 3 

 3. Indemnification. 

(a) General Indemnification. The Company shall indemnify Indemnitee, to the fullest extent permitted by applicable law in effect
on the date hereof or as amended to increase the scope of permitted indemnification, against Expenses, losses, liabilities, judgments, fines, penalties and amounts paid in settlement (including all interest, taxes, assessments and other charges in
connection therewith) incurred by Indemnitee or on Indemnitee’s behalf in connection with any Proceeding connected with, resulting from or relating to Indemnitee’s Corporate Status. 

(b) Additional Indemnification Regarding Expenses. Without limiting the foregoing, in the event any Proceeding is initiated by
Indemnitee, the Company or any other person (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) to enforce or interpret this Agreement or any rights of Indemnitee to indemnification or advancement of Expenses (or related
obligations of Indemnitee) under the Company’s or any such subsidiary’s certificate of incorporation, bylaws or other organizational agreement or instrument of the Company, any other agreement to which Indemnitee and the Company or any of
its subsidiaries are party, any vote of the stockholders or resolution of the directors of the Company or any of its subsidiaries, the DGCL, any other applicable law or any liability insurance policy, the Company shall indemnify Indemnitee against
Expenses incurred by Indemnitee or on Indemnitee’s behalf in connection with such Proceeding in proportion to the success achieved by Indemnitee in such Proceeding and the efforts required to obtain such success, as determined by the court
presiding over such Proceeding. 
 (c) Partial Indemnification. If Indemnitee is entitled under any provision of this
Agreement to indemnification by the Company for a portion of any Expenses, losses, liabilities, judgments, fines, penalties and amounts paid in settlement incurred by Indemnitee, but not for the total amount thereof, the Company shall nevertheless
indemnify Indemnitee for such portion. 
 (d) Nonexclusivity. The indemnification provided by this Agreement shall not be
deemed exclusive of any rights to which Indemnitee may be entitled under the certificate of incorporation, bylaws or other organizational agreement or instrument of the Company or any of its subsidiaries, any other agreement, any vote of the
stockholders or resolution of the directors, the DGCL, any other applicable law or any liability insurance policy. 
 (e)
Exceptions. Any other provision herein to the contrary notwithstanding, the Company shall not be obligated under the Agreement to indemnify Indemnitee: 
 (i) For Expenses incurred in connection with Proceedings initiated or brought voluntarily by Indemnitee and not by way of defense, counterclaim or crossclaim, except (x) as contemplated by
Section 3(b), (y) in specific cases if the Board of Directors has approved the initiation or bringing of such Proceeding, and (z) as may be required by law. 

(ii) For an accounting of profits arising from the purchase and sale by Indemnitee of securities within the meaning of
Section 16(b) of the Exchange Act, or any similar provisions of any federal, state or local law if the final, non-appealable judgment of a court of competent jurisdiction finds Indemnitee to be liable for disgorgement under such
Section 16(b). 

  
 4 

 (iii) On account of Indemnitee’s conduct that is established by a
final, non-appealable judgment of a court of competent jurisdiction as knowingly fraudulent or deliberately dishonest or that constituted willful misconduct. 
 (iv) For which payment is actually made to Indemnitee under a valid and collectible insurance policy or under a valid and enforceable indemnity clause, bylaw or agreement, except in respect of any excess
beyond payment actually received by Indemnitee under such insurance, clause, bylaw or agreement. 
 (v) if and to
the extent indemnification is prohibited by applicable law. 
 (f) Subrogation. In the event of payment under this
Agreement, the Company shall be subrogated to the extent of such payment to all of the rights of recovery of Indemnitee, who shall execute such documents and do such acts as the Company may reasonably request to secure such rights and to enable the
Company effectively to bring suit to enforce such rights. 
 4. Advancement of Expenses. 

The Company shall pay all Expenses incurred by Indemnitee in connection with any Proceeding connected with, resulting from or relating to
Indemnitee’s Corporate Status, other than a Proceeding initiated by Indemnitee for which the Company would not be obligated to indemnify Indemnitee pursuant to Section 3(e)(i), in advance of the final disposition (in accordance with
Section 5(c)) of such Proceeding and without regard to whether Indemnitee will ultimately be entitled to be indemnified for such Expenses and without regard to whether an Adverse Determination has been made, except as contemplated by the
last sentence of Section 5(f). The right to advances under this Section 4 shall in all instances continue until final disposition of any Proceeding, including any appeal therein. Advances shall be made without regard to
Indemnitee’s ability to repay the Expenses and without regard to Indemnitee’s ultimate entitlement to indemnification under the other provisions of this Agreement. Indemnitee shall qualify for advances upon the execution and delivery to
the Company of this Agreement, and Indemnitee shall repay such amounts advanced only if and to the extent that it shall ultimately be determined in a decision by a court of competent jurisdiction from which no appeal can be taken that Indemnitee is
not entitled to be indemnified by the Company for such Expenses. The right to advancement described in this Section 4 is vested. Any repayment obligation shall be unsecured and shall not bear interest. The Company shall not impose on
Indemnitee any additional conditions to advancement or require from Indemnitee additional undertakings regarding repayment. 

5. Indemnification Procedure. 
 (a) Notice of Proceeding; Cooperation. Indemnitee shall give the Company notice in writing as soon as practicable, and in any event, no later than thirty (30) days after Indemnitee becomes
aware, of any Proceeding for which indemnification will or could be sought under this Agreement, provided that any failure or delay in giving such notice shall not relieve the Company of its obligations under this Agreement unless and to the
extent that (i) none of the Company and its subsidiaries are party to or aware of such Proceeding and (ii) the Company is materially prejudiced by such failure or delay. 

  
 5 

 (b) Settlement. The Company will not, without the prior written consent of
Indemnitee, which may be provided or withheld in Indemnitee’s sole discretion, effect any settlement of any Proceeding against Indemnitee or which could have been brought against Indemnitee unless such settlement solely involves the payment of
money by persons other than Indemnitee and includes an unconditional release of Indemnitee from all liability on any matters that are the subject of such Proceeding and an acknowledgment that Indemnitee denies all wrongdoing in connection with such
matters. The Company shall not be obligated to indemnify Indemnitee against amounts paid in settlement of a Proceeding against Indemnitee if such settlement is effected by Indemnitee without the Company’s prior written consent, which shall not
be unreasonably withheld. 
 (c) Request for Payment; Timing of Payment. To obtain indemnification payments or advances
under this Agreement, Indemnitee shall submit to a Company a written request therefor, together with such invoices or other supporting information as may be reasonably requested by the Company and reasonably available to Indemnitee. The Company
shall make indemnification payments to Indemnitee no later than sixty (60) days, and advances to Indemnitee no later than twenty (20) days, after receipt of such written request from Indemnitee. 

(d) Determination. The Company intends that Indemnitee shall be indemnified to the fullest extent permitted by law as provided in
Section 3 and that no Determination shall be required in connection with such indemnification. In no event shall a Determination be required in connection with the advancement of Expenses pursuant to Section 4 or in connection with
the indemnification for Expenses incurred as a witness or incurred in connection with any Proceeding or portion thereof with respect to which Indemnitee has been successful on the merits or otherwise. Any decision that a Determination is required by
law in connection with any other indemnification of Indemnitee, and any such Determination, shall be made within 30 days after receipt of Indemnitee’s written request for indemnification, as follows: 

(i) If no Change in Control has occurred, (w) by a resolution of a majority of the directors of the Company
who are not parties to such Proceeding, even if less than a quorum, with the advice of Independent Legal Counsel, or (x) by a committee of such directors designated by a resolution of a majority of such directors, even if less than a
quorum, with the advice of Independent Legal Counsel, or (y) if there are no such directors, or if such directors so direct, by Independent Legal Counsel in a written opinion to the Company and Indemnitee, or (z) by the vote
of holders of shares of capital stock of the Company then outstanding that vote generally in the election of directors. 
 (ii) If a Change in Control has occurred, by Independent Legal Counsel in a written opinion to the Company and Indemnitee. 
 The Company shall pay all Expenses incurred by Indemnitee in connection with a Determination. 

  
 6 

 (e) Independent Legal Counsel. If there has not been a Change in Control, Independent
Legal Counsel shall be selected by the Board of Directors and approved by Indemnitee (which approval shall not be unreasonably withheld or delayed). If there has been a Change in Control, Independent Legal Counsel shall be selected by Indemnitee and
approved by the Company (which approval shall not be unreasonably withheld or delayed). The Company shall pay the fees and expenses of Independent Legal Counsel and indemnify Independent Legal Counsel against any and all expenses (including
attorneys’ fees), claims, liabilities and damages arising out of or relating to its engagement. 
 (f) Consequences of
Determination; Remedies of Indemnitee. The Company shall be bound by and shall have no right to challenge a Favorable Determination. If an Adverse Determination is made, or if for any other reason the Company does not make timely indemnification
payments or advances of Expenses, Indemnitee shall have the right to commence a Proceeding before a court of competent jurisdiction to challenge such Adverse Determination and/or to require the Company to make such payments or advances. Indemnitee
shall be entitled to be indemnified for all Expenses incurred in connection with such a Proceeding in accordance with Section 3(b) and to have such Expenses advanced by the Company in accordance with Section 4. If Indemnitee
fails to timely challenge an Adverse Determination, or if Indemnitee challenges an Adverse Determination and such Adverse Determination has been upheld by a final judgment of a court of competent jurisdiction from which no appeal can be taken, then,
to the extent and only to the extent required by such Adverse Determination or final judgment, the Company shall not be obligated to indemnify or advance Expenses to Indemnitee under this Agreement. 

(g) Presumptions; Burden and Standard of Proof. In connection with any Determination, or any review of any Determination, by any
person, including a court: 
 (i) It shall be a presumption that a Determination is not required. 

(ii) It shall be a presumption that Indemnitee has met the applicable standard of conduct and that indemnification of
Indemnitee is proper in the circumstances. 
 (iii) The burden of proof shall be on the Company to overcome the
presumptions set forth in the preceding clauses (i) and (ii), and each such presumption shall only be overcome if the Company establishes that there is no reasonable basis to support it. 

(iv) The termination of any Proceeding by judgment, order, finding, settlement (whether with or without court approval) or
conviction, or upon a plea of nolo contendere, or its equivalent, shall not create a presumption that indemnification is not proper or that Indemnitee did not meet the applicable standard of conduct or that a court has determined that
indemnification is not permitted by this Agreement or otherwise. 
 (v) Neither the failure of any person or
persons to have made a Determination nor an Adverse Determination by any person or persons shall be a defense to Indemnitee’s claim or create a presumption that Indemnitee did not meet the applicable standard of conduct, and any Proceeding
commenced by Indemnitee pursuant to Section 5(f) shall be de novo with respect to all determinations of fact and law. 

  
 7 

 6. Directors and Officers Liability Insurance. 

(a) Maintenance of Insurance. So long as the Company or any of its subsidiaries maintains liability insurance for any directors,
officers, employees or agents of any such person, the Company shall ensure that Indemnitee is covered by such insurance in such a manner as to provide Indemnitee the same rights and benefits as are accorded to the most favorably insured of the
Company’s and its subsidiaries’ then current directors and officers. If at any date (i) such insurance ceases to cover acts and omissions occurring during all or any part of the period of Indemnitee’s Corporate Status or
(ii) neither the Company nor any of its subsidiaries maintains any such insurance, the Company shall ensure that Indemnitee is covered, with respect to acts and omissions prior to such date, for at least six years (or such shorter period as is
available on commercially reasonable terms) from such date, by other directors and officers liability insurance, in amounts and on terms (including the portion of the period of Indemnitee’s Corporate Status covered) no less favorable to
Indemnitee than the amounts and terms of the liability insurance maintained by the Company on the date hereof. 
 (b) Notice
to Insurers. Upon receipt of written notice of a Proceeding pursuant to Section 5(a), the Company shall give or cause to be given prompt notice of such Proceeding to all insurers providing liability insurance in accordance with the
procedures set forth in all applicable or potentially applicable policies. The Company shall thereafter take all necessary action to cause such insurers to pay all amounts payable in accordance with the terms of such policies. 

7. Exculpation, etc. 
 (a) Limitation of Liability. Indemnitee shall not be personally liable to the Company or any of its subsidiaries or to the stockholders of the Company or any such subsidiary for monetary damages
for breach of fiduciary duty as a director or officer of the Company or any such subsidiary; provided, however, that the foregoing shall not eliminate or limit the liability of Indemnitee (i) for any breach of Indemnitee’s
duty of loyalty to the Company or such subsidiary or the stockholders thereof; (ii) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of the law; (iii) under
Section 174 of the DGCL or any similar provision of other applicable law; or (iv) for any transaction from which Indemnitee derived an improper personal benefit. If the DGCL or such other applicable law shall be amended to permit
further elimination or limitation of the personal liability of directors and/or officers, then the liability of Indemnitee shall, automatically, without any further action, be eliminated or limited to the fullest extent permitted by the DGCL or such
other applicable law as so amended. 
 (b) Period of Limitations. No legal action shall be brought and no cause of action
shall be asserted by or in the right of the Company or any of its subsidiaries against Indemnitee or Indemnitee’s estate, spouses, heirs, executors, personal or legal representatives, administrators or assigns after the expiration of two
(2) years from the date of accrual of such cause of action, and any claim or cause of action of the Company shall be extinguished and deemed released unless asserted by the timely filing of a legal action within such two (2) year period,
provided, however, that if any shorter period of limitations is otherwise applicable to any such cause of action, such shorter period shall govern. 

  
 8 

 8. Miscellaneous. 

(a) Non-Circumvention. The Company shall not seek or agree to any order of any court or other governmental authority that would
prohibit or otherwise interfere, and shall not take or fail to take any other action if such action or failure would reasonably be expected to have the effect of prohibiting or otherwise interfering, with the performance of the Company’s
indemnification, advancement or other obligations under this Agreement. 
 (b) Severability. If any provision or
provisions of this Agreement shall be held to be invalid, illegal or unenforceable for any reason whatsoever: (i) the validity, legality and enforceability of the remaining provisions of this Agreement (including without limitation, each
portion of any section of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) shall not in any way be affected or impaired thereby and shall remain
enforceable to the fullest extent permitted by law; (ii) such provision or provisions shall be deemed reformed to the extent necessary to conform to applicable law and to give the maximum effect to the intent of the parties hereto; and
(iii) to the fullest extent possible, the provisions of this Agreement (including, without limitation, each portion of any section of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that is not
itself invalid, illegal or unenforceable) shall be construed so as to give effect to the intent manifested thereby. 
 (c)
Notices. All notices, requests, demands and other communications under this Agreement shall be in writing and shall be deemed duly given (i) on the date of delivery if delivered personally, upon confirmation of receipt,
(ii) on the first business day following the date of dispatch if delivered by a nationally recognized courier service or (iii) on the third business day following the date of mailing if delivered by domestic registered or
certified mail, properly addressed, or on the fifth business day following the date of mailing if sent by airmail from a country outside of North America, to Indemnitee at the address shown on the signature page of this Agreement, to the Company at
the address shown on the signature page of this Agreement, or in either case at such address as subsequently modified by written notice to the other party. 
 (d) Amendment and Termination. No amendment, modification, termination or cancellation of this Agreement shall be effective unless it is in writing signed by all the parties hereto. No waiver of
any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provisions hereof (whether or not similar), nor shall such waiver constitute a continuing waiver. 

(e) Successors and Assigns. This Agreement shall be binding upon the Company and its respective successors and assigns, including
without limitation any acquiror of all or substantially all of the Company’s assets or business, any person (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) that acquires beneficial ownership of securities of the Company
representing more than 20% of the total voting power represented by the Company’s then outstanding Voting Securities and any survivor of any merger or consolidation to which the Company is party, and shall inure to the benefit of and be
enforceable by Indemnitee and Indemnitee’s estate, spouses, heirs, executors, personal or legal representatives, administrators and assigns. The Company shall require and cause any such successor, by written

  
 9 

 
agreement in form and substance satisfactory to Indemnitee, expressly to assume and agree to perform this Agreement as if it were named as the Company herein, and the Company shall not permit any
such purchase of assets or business, acquisition of securities or merger or consolidation to occur until such written agreement has been executed and delivered. No such assumption and agreement shall relieve the Company of any of its obligations
hereunder, and this Agreement shall not otherwise be assignable by the Company. This Agreement is personal in nature and neither of the parties hereto shall, without the consent of the other, assign or delegate this Agreement or any rights or
obligations. Without limiting the generality or effect of the foregoing, Indemnitee’s right to receive payments hereunder shall not be assignable, whether by pledge, creation of a security interest or otherwise, other than by a transfer by
Indemnitee’s will or by estate law, and, in the event of any attempted assignment or transfer contrary to this Section 8(e), the Company shall have no liability to pay any amount so attempted to be assigned or transferred.

 (f) Choice of Law; Consent to Jurisdiction. This Agreement shall be governed by and its provisions construed in
accordance with the laws of the State of Delaware, as applied to contracts between Delaware residents entered into and to be performed entirely within Delaware, without regard to the conflict of law principles thereof. The Company and Indemnitee
each hereby irrevocably consents to the jurisdiction of the courts of the State of Delaware for all purposes in connection with any Proceeding which arises out of or relates to this Agreement and agree that any action instituted under this Agreement
shall be brought only in the state courts in the State of Delaware. 
 (g) Integration and Entire Agreement. This
Agreement sets forth the entire understanding between the parties hereto and supersedes and merges all previous written and oral negotiations, commitments, understandings and agreements relating to the subject matter hereof between the parties
hereto, provided that the provisions hereof shall not supersede the provisions of the Company’s or any such subsidiary’s certificate of incorporation, bylaws or other organizational agreement or instrument of the Company, any other
agreement to which Indemnitee and the Company or any of its subsidiaries are party, any vote of the stockholders or resolution of the directors of the Company or any of its subsidiaries, the DGCL, any other applicable law or any liability insurance
policy, to the extent any such provisions shall be more favorable to Indemnitee than the provisions hereof. 
 (h)
Counterparts. This Agreement may be executed in one or more counterparts, each of which shall constitute an original, and all of which together shall constitute one and the same agreement. 

[Remainder of this page intentionally left blank] 

  
 10 

 IN WITNESS WHEREOF, the parties hereto have
executed and delivered this Indemnification Agreement as of the date first above written. 
  

			
	AMEDICA CORPORATION
		
	By:	 	 

 
			
	Name:	 	
	Title:	 	

  

			
	Address:	 	1885 West 2100 South
		 	Salt Lake, City, UT 84119

  

			
	AGREED TO AND ACCEPTED:
	
	INDEMNITEE
		
	By:	 	 

			
	Name:	 	
	Title:	 	

  

			
	Address:	 	 
		
		 	 
		
		 	 

  
 11

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00224-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00224-of-00352.parquet"}]]